ATR — AptarGroup, Inc. stock price, charts and financials

QT53AptarGroup, Inc.

AptarGroup, Inc. (NYSE: ATR) is a Healthcare company in the Medical - Instruments & Supplies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
133.73
-1.69-1.25%
OverviewShort InterestFilings
ATRQT53AptarGroup, Inc.·NYSE
133.73-1.25%
TA
Loading chart...
Signal & projected range
Insider selling clusterHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
AVTR+1.14%$13.74RGEN-0.45%$163.17BLCO+0.17%$16.81TFX-1.50%$132.96STVN+1.70%$20.61MMSI+0.80%$89.75BAX+0.87%$27.79SOLV+2.72%$85.24
Snapshot
Index-P/E24.18EPS (ttm)5.60Insider Own1.24%Shs Outstand63.82MPerf Week1.09%
Market Cap8.64BForward P/E21.41EPS next Y6.32Insider Trans-5.26%Shs Float62.95MPerf Month8.81%
Enterprise Value9.88BPEG-EPS next Q-Inst Own-Short Float2.92%Perf Quarter8.24%
Income362.12MP/S2.20EPS this Y-0.36%Inst Trans-Short Ratio3.63Perf Half Y9.23%
Sales3.93BP/B3.29EPS next Y14.78%ROA7.06%Short Interest1.84MPerf YTD11.04%
Book/sh-P/C14.82EPS next 5Y13.52%ROE13.52%52W High145.07 -7.82%Perf Year-2.25%
Cash/sh-P/FCF27.84EPS past 3/5Y17.88% 12.87%ROIC9.15%52W Low101.94 31.18%Perf 3Y10.78%
Dividend Est.1.92 (1.44%)EV/EBITDA12.02Sales past 3/5Y4.37% 5.22%Gross Margin28.26%Volatility2.28% 2.36%Perf 5Y5.04%
Dividend TTM1.92 (1.44%)EV/Sales2.51EPS Y/Y TTM0.00%Oper. Margin12.37%ATR (14)3.44Perf 10Y70.60%
Dividend Ex-DateJul 30, 2026Quick Ratio1.10Sales Y/Y TTM9.80%Profit Margin9.22%RSI (14)60.83Recom2.72
Dividend Gr. 3/5Y6.38% 4.91%Current Ratio1.61EPS Q/Q-0.83%SMA202.01%Beta0.38Target Price158.00
Payout33.84%Debt/Eq0.54Sales Q/Q6.31%SMA508.27%Rel Volume1.38Prev Close135.42
Employees14,000LT Debt/Eq0.44EarningsOct 29SMA2007.98%Avg Volume501.36KPrice133.73
IPO DateApr 23, 1993Option/ShortYes / YesEPS/Sales Surpr.3.48% 2.82%Net Debt/EBITDA1.50Volume691,291Change-1.25%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-15-26ReiteratedRaymond JamesOutperform$150 → $160
Mar-20-26UpgradeWells FargoEqual Weight → Overweight
Feb-09-26ReiteratedRobert W. Baird$145 → $156
Jan-09-26ReiteratedKeyBancHold$220
Jan-06-26DowngradeWells FargoOverweight → Equal Weight
Nov-03-25ReiteratedRobert W. Baird$160 → $145
Nov-03-25ReiteratedWells FargoOverweight$125 → $133
Oct-28-24ReiteratedRobert W. Baird$110 → $185
Oct-14-24UpgradeJefferiesHold → Buy$215
Apr-29-24UpgradeWilliam BlairMarket Perform → Outperform
Latest News
Aug-05-26
Aug-05-2611:31AM
AptarGroup Q2 Earnings Beat Estimates on Pharma & Beverage Growthzacks.com
Aug-04-26
Aug-04-2604:47AM
AptarGroup, Inc. $ATR Stock Position Raised by California State Teachers Retirement Systemdefenseworld.net
02:15AM
AptarGroup, Inc. (NYSE:ATR) Receives Average Recommendation of “Moderate Buy” from Brokeragesdefenseworld.net
Aug-03-26
Aug-03-2610:16AM
Why AptarGroup (ATR) International Revenue Trends Deserve Your Attentionzacks.com
Jul-31-26
Jul-31-2603:03PM
AptarGroup, Inc. (ATR) Q2 2026 Earnings Call Transcriptseekingalpha.com
12:04PM
AptarGroup Q2 Earnings Call Highlightsmarketbeat.com
Jul-30-26
Jul-30-2611:21PM
AptarGroup (NYSE:ATR) Tops Q2 Estimates, Shares Rise After HoursChartMill
08:31PM
AptarGroup (ATR) Tops Q2 Earnings and Revenue Estimateszacks.com
Jul-28-26
Jul-28-2607:59PM
AptarGroup Inc (ATR) Stock Up 3.3% and Still Undervalued -- GF Score: 82/100gurufocus.com
Jul-27-26
Jul-27-2605:00PM
Aptar Named One of the World's Most Sustainable Companies by TIME for Third Consecutive Yearbusinesswire.com
Jul-26-26
Jul-26-2603:50AM
First Trust Advisors LP Acquires 160,763 Shares of AptarGroup, Inc. $ATRdefenseworld.net
Jul-23-26
Jul-23-2602:12PM
Packaging Corp Q2 Earnings Beat Estimates on Record ShipmentsYahoo
11:06AM
AptarGroup (ATR) Expected to Beat Earnings Estimates: Should You Buy?zacks.com
Jul-20-26
Jul-20-2605:00PM
Aptar Beauty Launches Next-Generation Auto-Loading Dropper Technology for Easier, More Accurate Skincare Dosingbusinesswire.com
Jul-19-26
Jul-19-2604:11AM
Chicago Partners Investment Group LLC Invests $505,000 in AptarGroup, Inc. $ATRdefenseworld.net
Company

AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue3,9343,7773,583——————
Cost of Goods Sold Incl. D&A2,8222,6602,227——————
Gross Profit1,1121,1171,356——————
Selling, General and Administrative Excl. Other636500582——————
Research and Development3261050——————
Other Operating Expense-3360277——————
Operating Income487512496——————
Interest Expense645344——————
Unusual Expense
—————————
Non-Operating Income (Expense)323217——————
Net Income Before Taxes455491470——————
Income Taxes919996——————
Consolidated Net Income363393375——————
Net Income From Continuing Operations363392374——————
Net Income363393375——————
EPS (Recurring)5.605.975.65——————
EPS (Basic, Before Extraordinaries)5.605.975.65——————
EPS (Diluted)5.535.885.53——————
EBITDA822831777——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio24.1820.7428.41——————
Price To Sales Ratio2.182.132.89——————
Gross Margin28.2729.5737.85——————
Operating Margin12.3813.5613.84——————
Net Margin9.2310.4110.47——————
Shares Outstanding646666——————
Market Capitalization8,5598,04910,369——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$169.30$153.09$136.88$120.67$104.46● Close Price0.00M0.75M1.51M2.26M3.01MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Prieur MarcSegment PresidentAug 04 '26Sale136.263,500476,89715,823Aug 05
Tanda Stephan B.President and CEOAug 03 '26Sale136.169,8381,339,588238,729Aug 04
Tanda Stephan B.President and CEOAug 03 '26Option Exercise74.799,838735,784248,567Aug 04
Tlili HediSegment PresidentAug 03 '26Sale135.008,8541,195,29015,379Aug 03
Prieur MarcSegment PresidentJun 09 '26Sale115.585,000577,89419,323Jun 10
Vinczeller ShielaChief Human Resources OfficerJun 04 '26Sale112.613,555400,34127,078Jun 05
Gong XiangweiPresident, AsiaMay 26 '26Sale116.134,200487,76510,774May 27
Hudson Irene ElizabethEVP and Chief Legal OfficerMay 07 '26Option Exercise111.3884293,7822,322May 08
Hudson Irene ElizabethEVP and Chief Legal OfficerMay 07 '26Sale123.431,264156,0131,480May 08
Touya GaelSegment PresidentFeb 18 '26Sale141.353,500494,73927,963Feb 19
Prieur MarcSegment PresidentFeb 10 '26Sale137.812,000275,62013,745Feb 11
Ackerman DanielChief Accounting OfficerDec 12 '25Option Exercise71.1215,0001,066,80044,607Dec 15
Ackerman DanielChief Accounting OfficerDec 12 '25Sale121.2315,0001,818,43529,607Dec 15
Touya GaelSegment PresidentSep 11 '25Sale136.122,500340,29831,463Sep 12
Vinczeller ShielaChief Human Resources OfficerSep 05 '25Sale137.971,167161,00625,134Sep 08
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.